Download PDF
Semin Reprod Med 2004; 22(4): 361-368
DOI: 10.1055/s-2004-861552
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Adrenal Androgens and Aging

Sejal Dharia1 , C. Richard Parker1  Jr. 
  • 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
Further Information

Publication History

Publication Date:
05 January 2005 (online)

    Permissions and Reprints

ABSTRACT

Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) are the principal C19 steroids produced by the human adrenals. Their plasma levels decline to less than 20% of their maximal value during aging. Because these steroids appear to play a role in the maintenance of immunity, musculoskeletal integrity, and cardiovascular health, age-associated declines in adrenal androgen production may contribute to decreased immune function, osteoporosis, and atherosclerosis. Production of DHEA and DHEAS has been localized to the zona reticularis (ZR) of the adrenal cortex and can be modulated by intra-adrenal or extra-adrenal modulators. Extra-adrenal modulators include corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), insulin, and transforming growth factor β (TGF-β). Intra-adrenal regulators include enzymes and proteins involved in the steroidogenic pathway, specifically 17,20 lyase activity and DHEA sulfotransferase (DST). The natural histories of the emergence of adrenal androgen production and the ontogeny of the ZR appear to correlate closely. In addition, aging results in a decline in adrenal androgen production, and our data suggest a parallel diminution in the area represented by the ZR. This decline in the ZR may result from apoptosis, cellular and humoral immunity, or a reduction in the replicative capacity of the cells of the ZR.

KEYWORDS

Adrenal cortex - aging - androgens - zona reticularis - DHEA - DHEAS

REFERENCES

  • 1 Cooke B A, Vanha-Perttula T, Klopper A. Steroid biosynthesis in vitro by 6-8 week human foetal adrenal glands.  Scand J Clin Lab Invest. 1968;  21 30
    PubMedGoogle Scholar
  • 2 Labrie F, Belanger A, Luu-The V et al.. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.  Steroids. 1998;  63 322-328
    CrossrefPubMedGoogle Scholar
  • 3 Judd H L, Judd L E, Lucas W E, Yen S S. Endocrine function of postmenopausal ovaries: concentration of androgens and estrogens in ovarian and peripheral vein blood.  J Clin Endocrinol Metab. 1974;  39 1020-1024
    CrossrefPubMedGoogle Scholar
  • 4 Rosenfeld R S, Rosenberg B J, Fukushira O K, Hellman L. 24-h secretory pattern of dehydroepiandrosterone and dehydroepiandrosterone sulfate.  J Clin Endocrinol Metab. 1975;  40 850-855
    PubMedGoogle Scholar
  • 5 Parker Jr C R, Leveno K, Carr B R, Hauth J, MacDonald P C. Umbilical cord plasma levels of dehydroepiandrosterone sulfate during human gestation.  J Clin Endocrinol Metab. 1982;  54 1216-1220
    PubMedGoogle Scholar
  • 6 Siiteri P K, MacDonald P C. Placental estrogen biosynthesis during human pregnancy.  J Clin Endocrinol Metab. 1966;  26 751-761
    PubMedGoogle Scholar
  • 7 Migeon C J, Keller A R, Lawrence B, Shepard T H. Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex; day-to-day and diurnal variations.  J Clin Endocrinol Metab. 1957;  17 1051-1062
    PubMedGoogle Scholar
  • 8 Parker L N. Control of adrenal androgen secretion.  Endocrinol Metab Clin North Am. 1991;  20 401-421
    PubMedGoogle Scholar
  • 9 Parker Jr C R. Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging.  Steroids. 1999;  64 640-647
    CrossrefPubMedGoogle Scholar
  • 10 Azziz R, Fox L M, Zacur H A, Parker Jr C R, Boots L R. Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin.  J Clin Endocrinol Metab. 2001;  86 2513-2517
    CrossrefPubMedGoogle Scholar
  • 11 Isojarvi J, Pakarinen A, Ylipalosaari P, Myllyla V. Serum hormones in male epileptic patients receiving anticonvulsant medications.  Arch Neurol. 1990;  47 670-678
    PubMedGoogle Scholar
  • 12 Bhathena S, Berlin E, Judd J et al.. Hormones regulating lipid and carbohydrate metabolism in premenopausal women: modulation by dietary lipids.  Am J Clin Nutr. 1989;  49 752-757
    PubMedGoogle Scholar
  • 13 Khaw K, Tazuke S, Barrett-Conner E. Cigarette smoking and levels of adrenal androgens in postmenopausal women.  N Engl J Med. 1988;  318 1705-1709
    PubMedGoogle Scholar
  • 14 Labrie F, Belanger A, Cusan L, Gomez J L, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.  J Clin Endocrinol Metab. 1997;  82 2396-2402
    CrossrefPubMedGoogle Scholar
  • 15 Burger H G, Dudley E C, Cui J, Dennerstein L, Hopper J L. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate and sex hormone-binding globulin levels through the menopause transition.  J Clin Endocrinol Metab. 2000;  85 2832-2838
    CrossrefPubMedGoogle Scholar
  • 16 Parker Jr C R, Slayden S, Azziz R et al.. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women.  J Clin Endocrinol Metab. 2000;  85 48-54
    CrossrefPubMedGoogle Scholar
  • 17 Vermeulen A, Deslypere J P, Schelfhout W, Verdonck L, Rubens R. Adrenocortical function in old age: response to acute adrenocorticotropin stimulation.  J Clin Endocrinol Metab. 1982;  54 187-191
    PubMedGoogle Scholar
  • 18 Liu C H, Laughlin G A, Fischer U G, Yen S SC. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20 desmolase enzymatic activity.  J Clin Endocrinol Metab. 1990;  71 900-906
    PubMedGoogle Scholar
  • 19 Longcope C. The metabolism of dehydroepiandrosterone sulfate.  Semin Reprod Endocrinol. 1995;  13 270-274
    PubMedGoogle Scholar
  • 20 Sapolsky R M, Vogelman J H, Orentreich N, Altmann J. Senescent decline in serum dehydroepiandrosterone sulfate concentrations in a population of wild baboons.  J Gerontol. 1993;  48 B196-B200
    PubMedGoogle Scholar
  • 21 Lane M A, Ingram D K, Ball S S, Roth G S. Dehydroepiandrosterone sulfate. A biomarker of primate aging slowed by calorie restriction.  J Clin Endocrinol Metab. 1997;  82 2093-2096
    CrossrefPubMedGoogle Scholar
  • 22 Davis S R, Burger H G. Androgens and the postmenopausal woman.  J Clin Endocrinol Metab. 1996;  81 2759-2763
    CrossrefPubMedGoogle Scholar
  • 23 Schwartz A G, Pashko L, Whitcomb J M. Inhibition of tumor development by dehydroepiandrosterone and related steroids.  Toxicol Pathol. 1986;  14 357-362
    CrossrefPubMedGoogle Scholar
  • 24 Lucas J A, Ahmed S A, Casey M L, MacDonald P C. Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroepiandrosterone.  J Clin Invest. 1985;  75 2091-2093
    PubMedGoogle Scholar
  • 25 Meikle A W, Daynes R A, Araneo B A. Adrenal androgen secretion and biologic effects.  Endocrinol Metab Clin North Am. 1991;  20 381-399
    PubMedGoogle Scholar
  • 26 Flood J F, Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice.  Brain Res. 1988;  448 178-181
    CrossrefPubMedGoogle Scholar
  • 27 Sunderland T, Merril C R, Harrington M G. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease.  Lancet. 1989;  2 570
    PubMedGoogle Scholar
  • 28 Schneider L S, Hinsey M, Lyness S. Plasma dehydroepiandrosterone sulfate in Alzheimer's disease.  Biol Psychiatry. 1992;  31 205-208
    PubMedGoogle Scholar
  • 29 Notelovitz M. Androgen effects on bone and muscle.  Fertil Steril. 2002;  77 S34-S41
    PubMedGoogle Scholar
  • 30 Luo S, Labrie C, Belanger A, Labrie F. Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-Induced mammary carcinoma in the rat.  Endocrinology. 1997;  138 3387-3394
    CrossrefPubMedGoogle Scholar
  • 31 Bachmann G A. The hypoandrogenic woman: pathophysiologic overview.  Fertil Steril. 2002;  77 S72-S76
    CrossrefPubMedGoogle Scholar
  • 32 Dimitrakakis C, Zhou J, Bondy C A. Androgens and mammary growth and neoplasia.  Fertil Steril. 2002;  77 S26-S33
    PubMedGoogle Scholar
  • 33 Hollo I, Feher T, Szucs J. Serum dehydroepiandrosterone, androsterone and cortisol level in primary postmenopausal and other type osteoporosis.  Acta Med Acad Sci Hung. 1970;  27 155-160
    PubMedGoogle Scholar
  • 34 Loria R M, Inge T H, Cook S S, Szakal A K, Regelson W. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA).  J Med Virol. 1988;  26 301-134
    PubMedGoogle Scholar
  • 35 Pashko L, Schwartz A, Abou-Gharbia M et al.. Inhibition of DNA synthesis in mouse epidermis and breast epithelium by DHEA and related steroids.  Carcinogenesis. 1981;  2 717-721
    PubMedGoogle Scholar
  • 36 Barrett-Conner E, Khaw K T, Yen S SC. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease.  N Engl J Med. 1986;  315 1519-1524
    PubMedGoogle Scholar
  • 37 Herrington D M, Gordon G B, Achuff S C et al.. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography.  J Am Coll Cardiol. 1990;  16 862-870
    PubMedGoogle Scholar
  • 38 Kimura M, Tanaka S, Yamada Y et al.. Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats.  Endocrinology. 1998;  139 3249-3253
    CrossrefPubMedGoogle Scholar
  • 39 Gordon G B, Bush D E, Weisman H F. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesteremic New Zealand white rabbit with aortic intimal injury.  J Clin Invest. 1988;  82 712-720
    PubMedGoogle Scholar
  • 40 Nestler J E, Clore J N, Blackard W G. Dehydroepiandrosterone: the “missing link” between hyperinsulinemia and atherosclerosis?.  FASEB J. 1992;  6 3073
    PubMedGoogle Scholar
  • 41 Coleman D L, Leiter E H, Schwizer R W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.  Diabetes. 1982;  31 830-833
    CrossrefPubMedGoogle Scholar
  • 42 Shirley I M, Cooke B A. Localization of dehydroepiandrosterone sulphokinase and 3 beta-hydroxysteroid dehydrogenase-isomerase activities in the human foetal adrenal gland.  J Endocrinol. 1969;  45(Suppl) xxvi+
    PubMedGoogle Scholar
  • 43 Endoh A, Kristiansen S B, Casson P R, Buster J E, Hornsby P J. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3-beta hydroxysteroid dehydrogenase.  J Clin Endocrinol Metab. 1996;  81 3558-3565
    CrossrefPubMedGoogle Scholar
  • 44 Kennerson A R, McDonald D A, Adams J B. Dehydroepiandrosterone sulfotransferase localization in human adrenal glands: a light and electron microscopic study.  J Clin Endocrinol Metab. 1983;  56 786-790
    PubMedGoogle Scholar
  • 45 Conley A J, Bird I M. The role of cytochrome P450 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the delta 5 and delta 4 pathways of steroidogenesis in mammals.  Biol Reprod. 1997;  56 789-799
    CrossrefPubMedGoogle Scholar
  • 46 Mapes S, Corbin C J, Tarantal A, Conley A. The primate adrenal zona reticularis is defined by the expression of cytochrome b5, 17α hydroxylase/17,20 lyase cytochrome P450 (P450C17) and NADPH-cytochrome P450 reductase but not 3 beta-hydroxysteroid dehydrogenase/Δ5-4 isomerase (3βHSD).  J Clin Endocrinol Metab. 1999;  84 3382-3385
    CrossrefPubMedGoogle Scholar
  • 47 Parker Jr. C R, Jian M, Conley A J. The localization of DHEA sulfotransferase in steroidogenic and steroid metabolizing tissues of the adult rhesus macaque monkey.  Endocrine Res. 2000;  26 517-522
    PubMedGoogle Scholar
  • 48 L'Allemand D, Penhoat A, Lebrethon M C et al.. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells.  J Clin Endocrinol Metab. 1996;  81 3892-3897
    CrossrefPubMedGoogle Scholar
  • 49 Nestler J E, Clore J N, Strauss J F, Blackard W G. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.  J Clin Endocrinol Metab. 1987;  64 180-184
    PubMedGoogle Scholar
  • 50 Lebrethon M C, Jaillard C, Naville D, Begeot M, Saez J M. Effects of transforming growth factor-beta 1 on human adrenocortical fasciculata-reticularis cell differentiated functions.  J Clin Endocrinol Metab. 1994;  79 1033-1039
    CrossrefPubMedGoogle Scholar
  • 51 Stankovic A K, Dion L D, Parker Jr C R. Effects of transforming growth factor-beta on human fetal adrenal steroid production.  Mol Cell Endocrinol. 1994;  99 145-151
    CrossrefPubMedGoogle Scholar
  • 52 Lin D, Black S M, Nagahama Y, Miller W L. Steroid 17 alpha-hydroxylase and 17,20 lyase activities of p450C17: contributions of serine 106 and p450 reductase.  Endocrinology. 1993;  132 2498-2506
    CrossrefPubMedGoogle Scholar
  • 53 Zhang L H, Rodriguez H, Ohno S, Miller W L. Serine phosphorylation of human p450C17 increases 17,20 lyase activity: implications for adrenarche and for the polycystic ovary syndrome.  Proc Natl Acad Sci USA. 1995;  92 10619-10623
    CrossrefPubMedGoogle Scholar
  • 54 Katagiri M, Kagawa N, Waterman M R. The role of cytochrome b5 in the biosynthesis of androgens by human p450C17.  Arch Biochem Biophys. 1995;  317 343-347
    CrossrefPubMedGoogle Scholar
  • 55 Lee-Robichaud P, Wright J N, Akhtar M E, Akhtar M. Modulation of the activity of human 17 alpha hydroxylase-17,20 lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications.  Biochem J. 1995;  308 901-908
    PubMedGoogle Scholar
  • 56 Auchus R J, Lee T C, Miller W L. Cytochrome b5 augments the 17,20 lyase activity of human p450C17 without direct electron transfer.  J Biol Chem. 1998;  273 3158-3165
    CrossrefPubMedGoogle Scholar
  • 57 Dharia S P, Slane A, Jian M et al.. Co-localization of p450C17 and cytochrome b5 in androgen synthesizing tissues of the human.  Biol Reprod. 2004;  71 83-88
    CrossrefPubMedGoogle Scholar
  • 58 Rainey W E, Carr B R, Sasano H, Suzuki T, Mason J I. Dissecting human adrenal androgen production.  Trends Endocrinol Metab. 2002;  13 234-239
    CrossrefPubMedGoogle Scholar
  • 59 Suzuki T, Sasano H, Takeyama J et al.. Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies.  Clin Endocrinol. 2000;  53 739-747
    CrossrefPubMedGoogle Scholar
  • 60 Sakai Y, Yanase T, Takayanagi R et al.. High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome associated with high secretion of adrenal androgens.  J Clin Endocrinol Metab. 1993;  76 1286-1290
    CrossrefPubMedGoogle Scholar
  • 61 Yanase T, Sasano H, Yubisui T et al.. Immunohistochemical study of cytochrome b5 in human adrenal gland and in adrenocortical adenomas from patients with Cushing's syndrome.  Endocr J. 1998;  45 89-95
    PubMedGoogle Scholar
  • 62 Parker Jr. C R, Mixon R L, Brissie R M, Grizzle W E. Aging alters zonation in the adrenal cortex of men.  J Clin Endocrinol Metab. 1997;  82 3898-3901
    CrossrefPubMedGoogle Scholar
  • 63 Kreiner E, Dhom G. Age-related changes of the human adrenal gland [author's transl; in German].  Zentralbl Allg Pathol. 1979;  123 351-360
    PubMedGoogle Scholar
  • 64 Parker L N, Lifrak E T, Mamadan M B, Lai M K. Aging and the human zona reticularis.  Arch Androl. 1983;  10 17-20
    PubMedGoogle Scholar
  • 65 Dharia S P, Slane A, Conner M G, Parker Jr C R. Reduced Cytochrome b5: Cause for Adrenal Androgen Deficiency in Aging Women?. Proceedings of the 2003 Endocrine Society Annual Meeting June 26, 2003 Philadelphia, PA; Abstract #OR17-3
    Google Scholar
  • 66 Wolkersdorfer G W, Ehrhart-Bornstein M, Brauer S et al.. Differential regulation of apoptosis in the normal human adrenal gland.  J Clin Endocrinol Metab. 1996;  81 4129-4136
    CrossrefPubMedGoogle Scholar
  • 67 Spencer S J, Rabinovici J, Mesiano S, Goldsmith P C, Jaffe R B. Activin and inhibin in the human adrenal gland; regulation and differential effects in fetal and adult cells.  J Clin Invest. 1992;  90 142-149
    PubMedGoogle Scholar
  • 68 Vanttinen T, Liu J, Kivinen P, Voutilainen R. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.  J Endocrinol. 2003;  178 479-489
    CrossrefPubMedGoogle Scholar
  • 69 Stankovic A K, Grizzle W E, Stockard C R, Parker Jr C R. Interactions between transforming growth factor β and adrenocorticotropin in growth regulation of human adrenal fetal zone cells: possible involvement of adenylate cyclase.  Am J Physiol. 1994;  266 E495-E500
    PubMedGoogle Scholar
  • 70 Spencer S J, Mesiano S, Lee J Y, Jaffe R B. Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling.  J Clin Endocrinol Metab. 1999;  84 1110-1115
    CrossrefPubMedGoogle Scholar
  • 71 Hinshaw L B. Sepsis/septic shock: participation of the microcirculation: an abbreviated review.  Crit Care Med. 1996;  24 1072-1078
    PubMedGoogle Scholar
  • 72 Khoury E L, Berline J W. HLA-DR expression by adrenocortical cells of the zona reticularis: structural and allotypic characterization.  Tissue Antigens. 1988;  31 191-203
    PubMedGoogle Scholar
  • 73 Marx C, Bornstein S R, Wolkersdorfer G W et al.. Relevance of major histocompatibility complex class II expression as a hallmark for the cellular differentiation in the human adrenal cortex.  J Clin Endocrinol Metab. 1997;  82 3136-3140
    CrossrefPubMedGoogle Scholar
  • 74 Hayashi Y, Hiyoshi T, Takemura T, Kurashima C, Hirokawa K. Focal lymphocytic infiltration in the adrenal cortex of the elderly: immunohistochemical analysis of infiltrating lymphocytes.  Clin Exp Immunol. 1989;  77 101-105
    PubMedGoogle Scholar
  • 75 Hornsby P J. Aging of the human adrenal cortex.  Ageing Res Rev. 2002;  1 229-242
    PubMedGoogle Scholar
  • 76 Yang L, Suwa T, Wright W E, Shay J W, Hornsby P J. Telomere shortening and decline in replicative potential as a function of donor age in human adrenocortical cells.  Mech Ageing Dev. 2001;  122 1685-1694
    CrossrefPubMedGoogle Scholar

C. Richard Parker Jr.Ph.D. 

Professor, Department of Obstetrics and Gynecology, University of Alabama at Birmingham

618 South 20th Street, 360 Old Hillman Building

Birmingham, AL 35294-7333

Email: crparker@uab.edu